David W. Golde
6Patents
4h-index
18Co-inventors
50Inventor score
Filing activity: Jan 6, 1983 → Jun 13, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4438032A | Unique T-lymphocyte line and products derived therefrom | Emerging Cross-Sectional Technologies | 94 | Expired |
| US6406841B1 | Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides | Chemistry; Metallurgy | 39 | Expired |
| US6221904A | Method for increasing the concentration of ascorbic acid in brain tissues of a subject | Human Necessities | 25 | Expired |
| US6262111A | Method for increasing the concentration of ascorbic acid in brain tissues of a subject | Human Necessities | 5 | Expired |
| US6608106B2 | Method for increasing the concentration of ascorbic acid in brain tissues of a subject | Human Necessities | 2 | Expired |
| US6420420B2 | Method for increasing the concentration of ascorbic acid in brain tissue of a subject | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.